Viewing Study NCT03145961

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:10 PM
Ignite Modification Date: 2026-01-29 @ 8:56 PM
Study NCT ID: NCT03145961
Status: UNKNOWN
Last Update Posted: 2022-02-24
First Post: 2017-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients
Sponsor: Institute of Cancer Research, United Kingdom
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Triple Negative Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast cancer early stage View
None circulating tumour DNA View
None pembrolizumab View
None targeted therapy View
None randomised clinical trial View
None phase II View
None mutation screening View
None intermediate endpoint View